Latest Regulatory Compliance News

Clime Investment Management’s CIWO securities have been suspended from trading due to regulatory non-compliance, raising questions about the company’s next steps and investor impact.

Megaport Limited has announced a fully underwritten A$200 million equity raising to fund its acquisition of Latitude.sh, a global Compute-as-a-Service platform, alongside a strategic investment to accelerate network expansion in India. The acquisition is expected to significantly enhance Megaport’s revenue and EBITDA on a pro forma basis for FY25.

Bendigo and Adelaide Bank’s latest Basel III disclosures reveal a slight dip in capital ratios offset by improved liquidity and funding stability for the quarter ended September 2025.

Commonwealth Bank of Australia reported a 33 basis point increase in its CET1 capital ratio for Q3 2025, driven by earnings growth despite a rise in risk-weighted assets. Liquidity and leverage metrics remain robust, underscoring the bank's resilient capital position.

Lincoln Minerals Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information is driving the activity.

DroneShield Limited has retracted its recent announcement of $7.6 million in new U.S. Government orders, clarifying these were reissued contracts rather than fresh deals. The company is addressing the administrative error to prevent future confusion.

Critica Limited has demonstrated a 63% recovery of gallium oxide as a valuable by-product from its vast Jupiter rare earth deposit in Western Australia, integrating seamlessly into its existing beneficiation flowsheet. This milestone enhances the project’s strategic value amid global supply chain tensions.

BPM Minerals has cleared a key heritage survey hurdle at its Forelands Gold Project, enabling the start of a 3,000m drilling campaign targeting high-grade gold mineralisation at the Beachcomber Prospect.

SportsHero Limited has resumed trading on the ASX following a Supreme Court ruling addressing the company’s failure to lodge required cleansing notices for recent share issues.

Invex Therapeutics Ltd has been suspended from trading on the ASX due to a failure to maintain the minimum number of directors required by law. The suspension will remain until the company rectifies its governance structure and complies with listing rules.

Epsilon Healthcare has commenced operations of its new pharmacy division and extended a key loan facility, signaling a strategic pivot towards integrated healthcare and financial stability after recent restructuring.

Eagle Mountain Mining has requested a voluntary suspension of its ASX-listed securities pending a capital raising announcement, with trading expected to resume by 11 November 2025.